Comorbidities and outcomes: Advancing the field comes at a price

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1721-1723

  Sorror, Mohamed L ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CANCER MORTALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; NOTE; OVERALL SURVIVAL; PATIENT DECISION MAKING; PREOPERATIVE PERIOD; RELIABILITY; TREATMENT OUTCOME; VALIDITY;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE;

EID: 81255197749     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.10.026     Document Type: Note

References (12)

1. Birninger N., Bornhäuser M., Schaich M., Ehninger G., Schetelig J. The Hematopoietic Cell Transplantation-Specific Comorbidity Index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation-investigation of potential limitations of the index. Biol Blood Marrow Transplant 2011, 17:1824-1834.
2. Sorror M.L. Comorbidities and hematopoietic cell transplantation outcomes. Hematology 2010: American Society of Hematology Education Program Book 2010, 237-247. American Society of Hematology, Washington, DC. A.M. Gewirtz, J.R. Mikhael, B.S. Schwartz, M.A. Crowther (Eds.).
3. Sorror M.L., Storer B., Storb R. Assignment of scores for the Hematopoietic Cell Transplantation-Comorbidity Index: integer vs exact weights. Bone Marrow Transplant 2011, 46:464-466.
4. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
5. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
6. Streiner D.L., Norman G.R. Health Measurement Scales: A Practical Guide to Their Development 2003, Oxford University Press, Oxford, UK.
7. Sorror M.L., Ostronoff F., Storb R., et al. Multi-institutional validation of the predictive power of the hematopoietic cell transplantation comorbidity index (HCT-CI) for HCT outcomes. Blood 2011, (in press).
8. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000, 36:453-471.
9. Sorror M.L., Storb R., Sandmaier B.M., et al. Impact of comorbidities on early and late mortalities after allogeneic hematopoietic cell transplantation (HCT). Blood 2011, (in press).
10. Ostronoff F., Storer B., Storb R., et al. Interaction of age and comorbidities and their impacts on hematopoietic cell transplantation (HCT) outcomes. Blood 2011, (in press).
11. Walter R.B., Othus M., Borthakur G., et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol 2011, [Epub ahead of print].
12. Sorror M.L., Sandmaier B.M., Storer B.E., et al. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA 2011, 306:1874-1883.